Literature DB >> 28449490

Transcutaneous electrical acupoint stimulation (TEAS) ameliorates chemotherapy-induced bone marrow suppression in lung cancer patients.

Lili Hou1, Fen Gu2, Guanghui Gao3, Caicun Zhou3.   

Abstract

BACKGROUND: To investigate the effect of percutaneous electrical stimulation on chemotherapy-induced bone marrow suppression in patients with lung cancer.
METHODS: From December 2014 to August 2015, one hundred ninety-one non-small cell lung cancer patients with chemotherapy naive were randomly divided into control group, medication group, and transcutaneous electrical acupoint stimulation (TEAS) group. Patients with the control group received routine nursing care, the medication group was treated by oral administration of prophylactic agents, and TEAS group received electrical stimulation of acupoints including Dazhui (DU14), Geshu (BL17), Zusanli (ST36), Sanyinjiao (SP6), and Hegu (LI4). The primary end point was the blood routine indexes and secondary end point was the degree of comfort.
RESULTS: The white blood cell in the TEAS group was significantly higher than the control group on day 8 and day 14 (P<0.05). The platelet count in the TEAS group was significantly higher than control group on day 5, day 8 and day 11 (P<0.05). The comfort score in the TEAS group was significantly higher than control group on day 8 (P<0.05).
CONCLUSIONS: Percutaneous electrical stimulation of acupoints could prevent chemotherapy-induced bone marrow suppression in lung cancer patients and ensure a smooth continuation of chemotherapy.

Entities:  

Keywords:  Acupoint; bone marrow suppression; chemotherapy; electrical stimulation; lung cancer

Year:  2017        PMID: 28449490      PMCID: PMC5394020          DOI: 10.21037/jtd.2017.03.12

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  11 in total

1.  Factors affecting bone marrow toxicity following administration of carboplatin and paclitaxel in patients with non-small cell lung cancer.

Authors:  Apar Kishor Ganti; Fausto R Loberiza; Anne Kessinger
Journal:  Anticancer Res       Date:  2010-04       Impact factor: 2.480

Review 2.  Holistic comfort: operationalizing the construct as a nurse-sensitive outcome.

Authors:  K Y Kolcaba
Journal:  ANS Adv Nurs Sci       Date:  1992-09       Impact factor: 1.824

3.  Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy.

Authors:  Bjørn H Grønberg; Stein Sundstrøm; Stein Kaasa; Roy M Bremnes; Oystein Fløtten; Tore Amundsen; Harald H Hjelde; Christian von Plessen; Marit Jordhøy
Journal:  Eur J Cancer       Date:  2010-05-12       Impact factor: 9.162

4.  [Professor Li Shi-zhen's clinical experiences on compatibility application of hegu (LI 4)].

Authors:  Chuan-qi Li
Journal:  Zhongguo Zhen Jiu       Date:  2010-02

5.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

6.  Increased sensitivity to cisplatin in non-small cell lung cancer cell lines after FHIT gene transfer.

Authors:  F Andriani; P Perego; N Carenini; G Sozzi; L Roz
Journal:  Neoplasia       Date:  2006-01       Impact factor: 5.715

7.  [Effect of direct moxibustion at Sihua points on cytokine of chemotherapy patients with lung cancer].

Authors:  Qu-Fei Zhang; Li-Xia Li; Guo-Hua Lin; Li-Zhu Lin
Journal:  Zhongguo Zhen Jiu       Date:  2013-03

8.  Report of incidence and mortality in China cancer registries, 2009.

Authors:  Wanqing Chen; Rongshou Zheng; Siwei Zhang; Ping Zhao; Guanglin Li; Lingyou Wu; Jie He
Journal:  Chin J Cancer Res       Date:  2013-02       Impact factor: 5.087

9.  Prevalence and characteristics of adverse drug reactions in neurosurgical intensive care patients.

Authors:  Kelly M Smith; Chad S Jeske; Byron Young; Jimmi Hatton
Journal:  Neurosurgery       Date:  2006-03       Impact factor: 4.654

Review 10.  Economic burden of haematological adverse effects in cancer patients: a systematic review.

Authors:  S Y Liou; J M Stephens; K T Carpiuc; W Feng; M F Botteman; J W Hay
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

View more
  6 in total

1.  Randomized Efficacy Trial of Conventional, TCM Herb, and TEAS on Bone Marrow Suppression in Patients with Small Cell Lung Cancer after Initial Chemotherapy.

Authors:  Fangchao Zhao; Zengying Wang; Yanlin Gao; Yusi Wu; Jianming Liu; Shuangliang He
Journal:  Evid Based Complement Alternat Med       Date:  2021-02-02       Impact factor: 2.629

2.  Effectiveness of Acupuncture in Relieving Chemotherapy-induced Leukopenia in Patients With Breast Cancer: A Systematic Review With A Meta-Analysis and Trial Sequential Analysis.

Authors:  Ya Wen Shih; Jui Yuan Su; Yu Shan Kung; Yu Huei Lin; Duong Thi To Anh; Edi Sampurno Ridwan; Hsiu Ting Tsai
Journal:  Integr Cancer Ther       Date:  2021 Jan-Dec       Impact factor: 3.279

3.  Transcutaneous electrical acupoint stimulation (TEAS) for cancer-related fatigue: study protocol for a systematic review and meta-analysis.

Authors:  Yiwei Zeng; Jialin Xia; Zhihan Chen; Xiaoping Tian; Yulan Ren
Journal:  BMJ Open       Date:  2021-11-24       Impact factor: 2.692

Review 4.  Clinical Efficacy and Potential Mechanisms of Acupoint Stimulation Combined With Chemotherapy in Combating Cancer: A Review and Prospects.

Authors:  Shanshan Li; Suhong Zhao; Yi Guo; Yuanzhen Yang; Jin Huang; Jiaqi Wang; Shanshan Lu; Bin Wang; Chao Chai; Zhifang Xu; Yenlie Chin
Journal:  Front Oncol       Date:  2022-04-25       Impact factor: 5.738

5.  Transcutaneous electrical acupoint stimulation for pregnancy outcomes in women undergoing in vitro fertilization-embryo transfer: A systematic review and meta-analysis.

Authors:  Han Yang; Wen-Hui Hu; Gui-Xing Xu; Zi-Han Yin; Si-Yi Yu; Jia-Jia Liu; Zhi-Yong Xiao; Xiao-Yan Zheng; Jie Yang; Fan-Rong Liang
Journal:  Front Public Health       Date:  2022-08-11

6.  Acupuncture for the treatment of marrow suppression after chemotherapy: A protocol for systematic review and meta-analysis.

Authors:  Guoyan Geng; Zihan Yin; Mingsheng Sun; Guixing Xu; Jiao Chen; Fanrong Liang; Ling Zhao
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.